Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Nucl Med Biol. 2012 May 5;39(7):1053–1057. doi: 10.1016/j.nucmedbio.2012.04.001

Table 1.

Effect of fluvoxamine (25 mg/kg i.p.) or saline (control) on 5-HT synthesis rates in the rat brain regions and pineal body.

Structures 5-HT synthesis rate (pmol/g/min)a
ANOVA
Controls (N=8) Fluvoxamine (N=11) Percent differenceb F(1,17); p
Raphe nuclei
 -Dorsal 144±18 140±18 −3% 0.22 ; <0.60
 -Median 134±21 115±12 −14% 6.4; <0.02d
 -Magnus 62±9 43±10 −32% 18.1 ; <0.0006c
Cortices
 -Visual 30±5 41±7 38% 14.3; <0.001c
 -Auditory 26±6 43±9 65% 21.4; <0.003c
 -Parietal 29±7 39±9 37% 6.8; <0.02d
 -Sensory-motor 32±7 43±12 36% 5.4; <0.04d
 -Frontal 33±7 35±9 7% 0.27; >0.60
Basal ganglia
 -Globus pallidus 39±10 48±7 25% 5.36; <0.04d
 -Caudate-lateral 38±8 47±10 23% 4.4 ; <0.05d
 -Caudate-medial 54±9 60±10 12% 1.81; >0.10
 -Nucleus accumbens 65±9 68±6 4% 0.76; >0.30
Thalamus
 -Ventral 32±5 42±9 31% 7.99; <0.010c
 -Dorsal 38±6 46±9 23% 4.74; <0.050c
Hippocampus
 -Ventral 42±5 59±9 43% 23.0; <0.0002c
 -Dorsal 38±8 54±4 41% 33.0; <0.0003c
Substantia nigra
 -Reticulata 28±4 34±7 23% 4.7; <0.05d
 -Compacta 30±4 44±9 56% 16.7; <0.0008c
Geniculate body
 -Medial 30±6 45±10 48% 14.1; <0.002c
 -Lateral 43±7 47±9 8% 1.09; >0.3
VTA 43±6 50±9 15% 3.6; >0.07
MFB 48±6 39±9 −20% 6.00; <0.03d
Hypothalamus 34±5 40±6 18% 5.30; <0.04d
Superior colliculus 28±6 39±10 38% 7.60; <0.02c
Inferior colliculus 24±7 32±7 29% 6.0; <0.03d
Superior olive 34±17 34±11 2% 0.08; 1.000
Pineal body 705±262 1178±298 Not tested
a

5-HT synthesis rates are expressed as mean±SD. The number of animals is given in brackets.

b

Calculated as a percent (%) of the synthesis rates in the control group.

c

Significant difference in 5-HT synthesis rates between the fluvoxamine and control group following the Benjamini–Hochberg correction.

d

Identifies the brain regions with p<0.05 which lost significance following Benjamini–Hochberg correction.